Owner Glaxo Group Limited

Inventors Nichols, Paula Louise; Eatherton, Andrew John; Bamborough, Paul; Jandu, Karamjit Singh; Philps, Oliver James; Andreotti, Daniele

Agent Davies Collison Cave

Pub. Number AU-A-2010302842

PCT Pub. Number WO2011/038572

Priority PCT/ CN2010/001334 02.09.10 CN; 61/246,550 29.09.09 US

Filing date 27 September 2010

Wipo publication date 7 April 2011

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/42 (2006.01) - Oxazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07C 223/00 (2006.01) Compounds containing amino and CHO groups bound to the same carbon skeleton

C07C 233/00 (2006.01) Carboxylic acid amides

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 237/20 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 261/14 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms